51 related articles for article (PubMed ID: 21109982)
1. Overexpression of sorcin results in multidrug resistance in gastric cancer cells with up-regulation of P-gp.
He Q; Zhang G; Hou D; Leng A; Xu M; Peng J; Liu T
Oncol Rep; 2011 Jan; 25(1):237-43. PubMed ID: 21109982
[TBL] [Abstract][Full Text] [Related]
2. Sorcin a Potential Molecular Target for Cancer Therapy.
Shabnam B; Padmavathi G; Banik K; Girisa S; Monisha J; Sethi G; Fan L; Wang L; Mao X; Kunnumakkara AB
Transl Oncol; 2018 Dec; 11(6):1379-1389. PubMed ID: 30216763
[TBL] [Abstract][Full Text] [Related]
3. Reversal of Multidrug Resistance by the Chinese Medicine Yiqi Jianpi Huaji Decoction and the Mechanism of Action in Human Gastric Cancer SGC7901/VCR Cells.
Li WB; Li Y; Yu C; He YM
Evid Based Complement Alternat Med; 2015; 2015():390812. PubMed ID: 25705237
[TBL] [Abstract][Full Text] [Related]
4. Development of a CD8+ T cell associated signature for predicting the prognosis and immunological characteristics of gastric cancer by integrating single-cell and bulk RNA-sequencing.
Li J; Han T; Wang X; Wang Y; Yang R; Yang Q
Sci Rep; 2024 Feb; 14(1):4524. PubMed ID: 38402299
[TBL] [Abstract][Full Text] [Related]
5. Sorcin promotes migration in cancer and regulates the EGF-dependent EGFR signaling pathways.
Tito C; Genovese I; Giamogante F; Benedetti A; Miglietta S; Barazzuol L; Cristiano L; Iaiza A; Carolini S; De Angelis L; Masciarelli S; Nottola SA; Familiari G; Petrozza V; Lauriola M; Tamagnone L; Ilari A; Calì T; Valdivia HH; Valdivia CR; Colotti G; Fazi F
Cell Mol Life Sci; 2023 Jul; 80(8):202. PubMed ID: 37442828
[TBL] [Abstract][Full Text] [Related]
6. Clinical Significance and Prognostic Value of Human Soluble Resistance-Related Calcium-Binding Protein: A Pan-Cancer Analysis.
Zhang J; Chen J; Shan B; Lin L; Dong J; Sun Q; Zhou Q; Han X
Front Med (Lausanne); 2021; 8():752619. PubMed ID: 34869449
[TBL] [Abstract][Full Text] [Related]
7. A novel homeostatic loop of sorcin drives paclitaxel-resistance and malignant progression via Smad4/ZEB1/miR-142-5p in human ovarian cancer.
Zhang J; Guan W; Xu X; Wang F; Li X; Xu G
Oncogene; 2021 Jul; 40(30):4906-4918. PubMed ID: 34163033
[TBL] [Abstract][Full Text] [Related]
8. Mitochondria: Insights into Crucial Features to Overcome Cancer Chemoresistance.
Genovese I; Carinci M; Modesti L; Aguiari G; Pinton P; Giorgi C
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33946271
[TBL] [Abstract][Full Text] [Related]
9. Flightless-1 inhibits ER stress-induced apoptosis in colorectal cancer cells by regulating Ca
Choi SS; Lee SK; Kim JK; Park HK; Lee E; Jang J; Lee YH; Khim KW; Hyun JM; Eom HJ; Lee S; Kang BH; Chae YC; Myung K; Myung SJ; Park CY; Choi JH
Exp Mol Med; 2020 Jun; 52(6):940-950. PubMed ID: 32504039
[TBL] [Abstract][Full Text] [Related]
10. Roles of Sorcin in Drug Resistance in Cancer: One Protein, Many Mechanisms, for a Novel Potential Anticancer Drug Target.
Battista T; Fiorillo A; Chiarini V; Genovese I; Ilari A; Colotti G
Cancers (Basel); 2020 Apr; 12(4):. PubMed ID: 32268494
[TBL] [Abstract][Full Text] [Related]
11. Sorcin: a novel potential target in therapies of cancers.
Zhou X; Wu X; Chen B
Cancer Manag Res; 2019; 11():7327-7336. PubMed ID: 31496794
[TBL] [Abstract][Full Text] [Related]
12. miR‑1 reverses multidrug resistance in gastric cancer cells via downregulation of sorcin through promoting the accumulation of intracellular drugs and apoptosis of cells.
Deng LM; Tan T; Zhang TY; Xiao XF; Gu H
Int J Oncol; 2019 Aug; 55(2):451-461. PubMed ID: 31268161
[TBL] [Abstract][Full Text] [Related]
13. Sorcin Predicts Poor Prognosis and Promotes Metastasis by Facilitating Epithelial-mesenchymal Transition in Hepatocellular Carcinoma.
Lei X; Liang Y; Chen J; Xiao S; Lei J; Li J; Duanmu J; Jiang Q; Liu D; Tang C; Li T
Sci Rep; 2017 Aug; 7(1):10049. PubMed ID: 28855589
[TBL] [Abstract][Full Text] [Related]
14. Binding of doxorubicin to Sorcin impairs cell death and increases drug resistance in cancer cells.
Genovese I; Fiorillo A; Ilari A; Masciarelli S; Fazi F; Colotti G
Cell Death Dis; 2017 Jul; 8(7):e2950. PubMed ID: 28726784
[TBL] [Abstract][Full Text] [Related]
15. What gastric cancer proteomic studies show about gastric carcinogenesis?
Leal MF; Wisnieski F; de Oliveira Gigek C; do Santos LC; Calcagno DQ; Burbano RR; Smith MC
Tumour Biol; 2016 Aug; 37(8):9991-10010. PubMed ID: 27126070
[TBL] [Abstract][Full Text] [Related]
16. Role of miR-27a, miR-181a and miR-20b in gastric cancer hypoxia-induced chemoresistance.
Danza K; Silvestris N; Simone G; Signorile M; Saragoni L; Brunetti O; Monti M; Mazzotta A; De Summa S; Mangia A; Tommasi S
Cancer Biol Ther; 2016 Apr; 17(4):400-6. PubMed ID: 26793992
[TBL] [Abstract][Full Text] [Related]
17. Structural basis of Sorcin-mediated calcium-dependent signal transduction.
Ilari A; Fiorillo A; Poser E; Lalioti VS; Sundell GN; Ivarsson Y; Genovese I; Colotti G
Sci Rep; 2015 Nov; 5():16828. PubMed ID: 26577048
[TBL] [Abstract][Full Text] [Related]
18. The potential predictive role of nuclear NHERF1 expression in advanced gastric cancer patients treated with epirubicin/oxaliplatin/capecitabine first line chemotherapy.
Mangia A; Caldarola L; Dell'Endice S; Scarpi E; Saragoni L; Monti M; Santini D; Brunetti O; Simone G; Silvestris N
Cancer Biol Ther; 2015; 16(8):1140-7. PubMed ID: 26126066
[TBL] [Abstract][Full Text] [Related]
19. shRNA-mediated silencing of sorcin increases drug chemosensitivity in myeloma KM3/DDP and U266/ADM cell lines.
Xu P; Jiang YF; Wang JH
Int J Clin Exp Pathol; 2015; 8(3):2300-10. PubMed ID: 26045737
[TBL] [Abstract][Full Text] [Related]
20. Sorafenib reverses resistance of gastric cancer to treatment by cisplatin through down-regulating MDR1 expression.
Huang YS; Xue Z; Zhang H
Med Oncol; 2015 Feb; 32(2):470. PubMed ID: 25579168
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
